Latest filing published 13 Jun 2024 for LifeStance Health Group, Inc., €438k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kevin Michael Mullins is a declared insider of LifeStance Health Group, Inc. (senior executive), with filings sourced from SEC (Form 4). We count 23 filings; the first trade dates from 20 April 2022 and the latest from 11 June 2024.
Sales make up the whole of the open-market record (20 sales, €8.9M). The rest of the record consists of 3 share grants. Since January 2024: no purchases and 4 sales on the market.
The latest filing, published on 13 June 2024, reports an open-market sale of €438k in LifeStance Health Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations